[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Europe Huntington's Disease Therapeutics Market Report 2016

November 2016 | 128 pages | ID: E66993C76C6EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Huntington's Disease Therapeutics

Revenue, means the sales value of Huntington's Disease Therapeutics

This report studies sales (consumption) of Huntington's Disease Therapeutics in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
  • Auspex Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Intellect Neurosciences Incorporation
  • Lundbeck A/S
  • Prana Biotechnology Limited
  • Raptor Pharmaceuticals
  • Sangamo Biosciences
  • Teva Pharmaceutical Industries
  • Trophos SA
  • Valeant Pharmaceuticals International
  • Vertex Pharmaceuticals
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Huntington's Disease Therapeutics in these countries, from 2011 to 2021 (forecast), like
  • Germany
  • France
  • UK
  • Russia
  • Italy
  • Spain
  • Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on sales, market share and growth rate of Huntington's Disease Therapeutics in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Europe Huntington's Disease Therapeutics Market Report 2016

1 HUNTINGTON'S DISEASE THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Huntington's Disease Therapeutics
1.2 Classification of Huntington's Disease Therapeutics
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Huntington's Disease Therapeutics
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Huntington's Disease Therapeutics Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Huntington's Disease Therapeutics (2011-2021)
  1.5.1 Europe Huntington's Disease Therapeutics Sales and Growth Rate (2011-2021)
  1.5.2 Europe Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)

2 EUROPE HUNTINGTON'S DISEASE THERAPEUTICS BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Huntington's Disease Therapeutics Market Competition by Manufacturers
  2.1.1 Europe Huntington's Disease Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Huntington's Disease Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Huntington's Disease Therapeutics (Volume and Value) by Type
  2.2.1 Europe Huntington's Disease Therapeutics Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Huntington's Disease Therapeutics Revenue and Market Share by Type (2011-2016)
2.3 Europe Huntington's Disease Therapeutics (Volume and Value) by Countries
  2.3.1 Europe Huntington's Disease Therapeutics Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Huntington's Disease Therapeutics Revenue and Market Share by Countries (2011-2016)
2.4 Europe Huntington's Disease Therapeutics (Volume) by Application

3 GERMANY HUNTINGTON'S DISEASE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Huntington's Disease Therapeutics Sales and Value (2011-2016)
  3.1.1 Germany Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
  3.1.2 Germany Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
3.2 Germany Huntington's Disease Therapeutics Sales and Market Share by Manufacturers
3.3 Germany Huntington's Disease Therapeutics Sales and Market Share by Type
3.4 Germany Huntington's Disease Therapeutics Sales and Market Share by Application

4 FRANCE HUNTINGTON'S DISEASE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

4.1 France Huntington's Disease Therapeutics Sales and Value (2011-2016)
  4.1.1 France Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
  4.1.2 France Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
  4.1.4 France Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
4.2 France Huntington's Disease Therapeutics Sales and Market Share by Manufacturers
4.3 France Huntington's Disease Therapeutics Sales and Market Share by Type
4.4 France Huntington's Disease Therapeutics Sales and Market Share by Application

5 UK HUNTINGTON'S DISEASE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

5.1 UK Huntington's Disease Therapeutics Sales and Value (2011-2016)
  5.1.1 UK Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
  5.1.2 UK Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
  5.1.5 UK Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
5.2 UK Huntington's Disease Therapeutics Sales and Market Share by Manufacturers
5.3 UK Huntington's Disease Therapeutics Sales and Market Share by Type
5.4 UK Huntington's Disease Therapeutics Sales and Market Share by Application

6 RUSSIA HUNTINGTON'S DISEASE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Huntington's Disease Therapeutics Sales and Value (2011-2016)
  6.1.1 Russia Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
  6.1.2 Russia Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
6.2 Russia Huntington's Disease Therapeutics Sales and Market Share by Manufacturers
6.3 Russia Huntington's Disease Therapeutics Sales and Market Share by Type
6.4 Russia Huntington's Disease Therapeutics Sales and Market Share by Application

7 ITALY HUNTINGTON'S DISEASE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Huntington's Disease Therapeutics Sales and Value (2011-2016)
  7.1.1 Italy Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
  7.1.2 Italy Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
7.2 Italy Huntington's Disease Therapeutics Sales and Market Share by Manufacturers
7.3 Italy Huntington's Disease Therapeutics Sales and Market Share by Type
7.4 Italy Huntington's Disease Therapeutics Sales and Market Share by Application

8 SPAIN HUNTINGTON'S DISEASE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Huntington's Disease Therapeutics Sales and Value (2011-2016)
  8.1.1 Spain Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
  8.1.2 Spain Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
8.2 Spain Huntington's Disease Therapeutics Sales and Market Share by Manufacturers
8.3 Spain Huntington's Disease Therapeutics Sales and Market Share by Type
8.4 Spain Huntington's Disease Therapeutics Sales and Market Share by Application

9 BENELUX HUNTINGTON'S DISEASE THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Huntington's Disease Therapeutics Sales and Value (2011-2016)
  9.1.1 Benelux Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
9.2 Benelux Huntington's Disease Therapeutics Sales and Market Share by Manufacturers
9.3 Benelux Huntington's Disease Therapeutics Sales and Market Share by Type
9.4 Benelux Huntington's Disease Therapeutics Sales and Market Share by Application

10 EUROPE HUNTINGTON'S DISEASE THERAPEUTICS MANUFACTURERS ANALYSIS

10.1 Auspex Pharmaceuticals
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Auspex Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Alnylam Pharmaceuticals
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Alnylam Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Intellect Neurosciences Incorporation
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Intellect Neurosciences Incorporation Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Lundbeck A/S
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Lundbeck A/S Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Prana Biotechnology Limited
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Prana Biotechnology Limited Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Raptor Pharmaceuticals
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Raptor Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Sangamo Biosciences
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 Sangamo Biosciences Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Teva Pharmaceutical Industries
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Trophos SA
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Trophos SA Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Valeant Pharmaceuticals International
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Huntington's Disease Therapeutics Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 Valeant Pharmaceuticals International Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Vertex Pharmaceuticals

11 HUNTINGTON'S DISEASE THERAPEUTICS MANUFACTURING COST ANALYSIS

11.1 Huntington's Disease Therapeutics Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Huntington's Disease Therapeutics

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Huntington's Disease Therapeutics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Huntington's Disease Therapeutics Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE HUNTINGTON'S DISEASE THERAPEUTICS MARKET FORECAST (2016-2021)

14.1 Germany Huntington's Disease Therapeutics Sales Forecast (2016-2021)
14.2 France Huntington's Disease Therapeutics Sales Forecast (2016-2021)
14.3 UK Huntington's Disease Therapeutics Sales Forecast (2016-2021)
14.4 Russia Huntington's Disease Therapeutics Sales Forecast (2016-2021)
14.5 Italy Huntington's Disease Therapeutics Sales Forecast (2016-2021)
14.6 Spain Huntington's Disease Therapeutics Sales Forecast (2016-2021)
14.7 Benelux Huntington's Disease Therapeutics Sales Forecast (2016-2021)
14.8 Europe Huntington's Disease Therapeutics Sales Forecast by Type (2016-2021)
14.9 Europe Huntington's Disease Therapeutics Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
LIST OF TABLES AND FIGURES

Figure Picture of Huntington's Disease Therapeutics
Table Classification of Huntington's Disease Therapeutics
Figure Europe Sales Market Share of Huntington's Disease Therapeutics by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Huntington's Disease Therapeutics
Figure Europe Sales Market Share of Huntington's Disease Therapeutics by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)
Figure France Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)
Figure UK Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)
Figure Russia Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)
Figure Italy Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)
Figure Spain Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)
Figure Benelux Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)
Figure Europe Huntington's Disease Therapeutics Sales and Growth Rate (2011-2021)
Figure Europe Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2021)
Table Europe Huntington's Disease Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table Europe Huntington's Disease Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Huntington's Disease Therapeutics Sales Share by Manufacturers
Figure 2016 Huntington's Disease Therapeutics Sales Share by Manufacturers
Table Europe Huntington's Disease Therapeutics Revenue by Manufacturers (2015 and 2016)
Table Europe Huntington's Disease Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Huntington's Disease Therapeutics Revenue Share by Manufacturers
Table 2016 Europe Huntington's Disease Therapeutics Revenue Share by Manufacturers
Table Europe Huntington's Disease Therapeutics Sales and Market Share by Type (2011-2016)
Table Europe Huntington's Disease Therapeutics Sales Share by Type (2011-2016)
Figure Sales Market Share of Huntington's Disease Therapeutics by Type (2011-2016)
Figure Europe Huntington's Disease Therapeutics Sales Growth Rate by Type (2011-2016)
Table Europe Huntington's Disease Therapeutics Revenue and Market Share by Type (2011-2016)
Table Europe Huntington's Disease Therapeutics Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Huntington's Disease Therapeutics by Type (2011-2016)
Figure Europe Huntington's Disease Therapeutics Revenue Growth Rate by Type (2011-2016)
Table Europe Huntington's Disease Therapeutics Sales and Market Share by Countries (2011-2016)
Table Europe Huntington's Disease Therapeutics Sales Share by Countries (2011-2016)
Figure Sales Market Share of Huntington's Disease Therapeutics by Countries (2011-2016)
Table Europe Huntington's Disease Therapeutics Revenue and Market Share by Countries (2011-2016)
Table Europe Huntington's Disease Therapeutics Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Huntington's Disease Therapeutics by Countries (2011-2016)
Table Europe Huntington's Disease Therapeutics Sales and Market Share by Application (2011-2016)
Table Europe Huntington's Disease Therapeutics Sales Share by Application (2011-2016)
Figure Sales Market Share of Huntington's Disease Therapeutics by Application (2011-2016)
Figure Germany Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
Figure Germany Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
Figure Germany Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
Table Germany Huntington's Disease Therapeutics Sales by Manufacturers (2015 and 2016)
Table Germany Huntington's Disease Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Germany Huntington's Disease Therapeutics Sales by Type (2015 and 2016)
Table Germany Huntington's Disease Therapeutics Market Share by Type (2015 and 2016)
Table Germany Huntington's Disease Therapeutics Sales by Application (2015 and 2016)
Table Germany Huntington's Disease Therapeutics Market Share by Application (2015 and 2016)
Figure France Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
Figure France Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
Figure France Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
Table France Huntington's Disease Therapeutics Sales by Manufacturers (2015 and 2016)
Table France Huntington's Disease Therapeutics Market Share by Manufacturers (2015 and 2016)
Table France Huntington's Disease Therapeutics Sales by Type (2015 and 2016)
Table France Huntington's Disease Therapeutics Market Share by Type (2015 and 2016)
Table France Huntington's Disease Therapeutics Sales by Application (2015 and 2016)
Table France Huntington's Disease Therapeutics Market Share by Application (2015 and 2016)
Figure UK Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
Figure UK Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
Figure UK Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
Table UK Huntington's Disease Therapeutics Sales by Manufacturers (2015 and 2016)
Table UK Huntington's Disease Therapeutics Market Share by Manufacturers (2015 and 2016)
Table UK Huntington's Disease Therapeutics Sales by Type (2015 and 2016)
Table UK Huntington's Disease Therapeutics Market Share by Type (2015 and 2016)
Table UK Huntington's Disease Therapeutics Sales by Application (2015 and 2016)
Table UK Huntington's Disease Therapeutics Market Share by Application (2015 and 2016)
Figure Russia Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
Figure Russia Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
Figure Russia Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
Table Russia Huntington's Disease Therapeutics Sales by Manufacturers (2015 and 2016)
Table Russia Huntington's Disease Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Russia Huntington's Disease Therapeutics Sales by Type (2015 and 2016)
Table Russia Huntington's Disease Therapeutics Market Share by Type (2015 and 2016)
Table Russia Huntington's Disease Therapeutics Sales by Application (2015 and 2016)
Table Russia Huntington's Disease Therapeutics Market Share by Application (2015 and 2016)
Figure Italy Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
Figure Italy Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
Figure Italy Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
Table Italy Huntington's Disease Therapeutics Sales by Manufacturers (2015 and 2016)
Table Italy Huntington's Disease Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Italy Huntington's Disease Therapeutics Sales by Type (2015 and 2016)
Table Italy Huntington's Disease Therapeutics Market Share by Type (2015 and 2016)
Table Italy Huntington's Disease Therapeutics Sales by Application (2015 and 2016)
Table Italy Huntington's Disease Therapeutics Market Share by Application (2015 and 2016)
Figure Spain Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
Figure Spain Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
Figure Spain Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
Table Spain Huntington's Disease Therapeutics Sales by Manufacturers (2015 and 2016)
Table Spain Huntington's Disease Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Spain Huntington's Disease Therapeutics Sales by Type (2015 and 2016)
Table Spain Huntington's Disease Therapeutics Market Share by Type (2015 and 2016)
Table Spain Huntington's Disease Therapeutics Sales by Application (2015 and 2016)
Table Spain Huntington's Disease Therapeutics Market Share by Application (2015 and 2016)
Figure Benelux Huntington's Disease Therapeutics Sales and Growth Rate (2011-2016)
Figure Benelux Huntington's Disease Therapeutics Revenue and Growth Rate (2011-2016)
Figure Benelux Huntington's Disease Therapeutics Sales Price Trend (2011-2016)
Table Benelux Huntington's Disease Therapeutics Sales by Manufacturers (2015 and 2016)
Table Benelux Huntington's Disease Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Benelux Huntington's Disease Therapeutics Sales by Type (2015 and 2016)
Table Benelux Huntington's Disease Therapeutics Market Share by Type (2015 and 2016)
Table Benelux Huntington's Disease Therapeutics Sales by Application (2015 and 2016)
Table Benelux Huntington's Disease Therapeutics Market Share by Application (2015 and 2016)
Table Huntington's Disease Therapeutics Basic Information List
Table Auspex Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Auspex Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alnylam Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Intellect Neurosciences Incorporation Basic Information List
Table Intellect Neurosciences Incorporation Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intellect Neurosciences Incorporation Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Lundbeck A/S Basic Information List
Table Lundbeck A/S Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lundbeck A/S Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Prana Biotechnology Limited Basic Information List
Table Prana Biotechnology Limited Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Prana Biotechnology Limited Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Raptor Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Sangamo Biosciences Basic Information List
Table Sangamo Biosciences Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sangamo Biosciences Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Trophos SA Basic Information List
Table Trophos SA Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Trophos SA Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Valeant Pharmaceuticals International Basic Information List
Table Valeant Pharmaceuticals International Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Valeant Pharmaceuticals International Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Vertex Pharmaceuticals Basic Information List
Table Vertex Pharmaceuticals Huntington's Disease Therapeutics Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vertex Pharmaceuticals Huntington's Disease Therapeutics Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Huntington's Disease Therapeutics
Figure Manufacturing Process Analysis of Huntington's Disease Therapeutics
Figure Huntington's Disease Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Huntington's Disease Therapeutics Major Manufacturers in 2015
Table Major Buyers of Huntington's Disease Therapeutics
Table Distributors/Traders List
Figure Germany Huntington's Disease Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Germany Huntington's Disease Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure France Huntington's Disease Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure France Huntington's Disease Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure UK Huntington's Disease Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure UK Huntington's Disease Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Huntington's Disease Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Russia Huntington's Disease Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Huntington's Disease Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Italy Huntington's Disease Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Huntington's Disease Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Spain Huntington's Disease Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Huntington's Disease Therapeutics Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Huntington's Disease Therapeutics Revenue and Growth Rate Forecast (2016-2021)
Table Europe Huntington's Disease Therapeutics Sales Forecast by Type (2016-2021)
Table Europe Huntington's Disease Therapeutics Sales Forecast by Application (2016-2021)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories